We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.17B
1-Year Est. Return 92.19%
This Fund
S&P 500
This Quarter Est. Return
+32.88%
1 Year Est. Return
+92.19%
3 Year Est. Return
+240.57%
5 Year Est. Return
+377.11%
10 Year Est. Return
+3,179.38%
AUM
$1.17B
AUM Growth
+$68.7M
Cap. Flow
+$9.42M
Cap. Flow %
0.81%
Top 10 Hldgs %
33.9%
Holding
116
New
34
Increased
23
Reduced
41
Closed
18

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$26.9M
2
ASND icon
Ascendis Pharma A/S
ASND
+$19M
3
MTD icon
Mettler-Toledo International
MTD
+$16.1M
4
MRK icon
Merck
MRK
+$14.9M
5
CYTK icon
Cytokinetics
CYTK
+$13.8M

Top Sells

Rank Stock Value
1
THC icon
Tenet Healthcare
THC
+$50M
2
LLY icon
Eli Lilly
LLY
+$27.1M
3
PEN icon
Penumbra
PEN
+$25.8M
4
GKOS icon
Glaukos
GKOS
+$23.2M
5
CNTA
Centessa Pharmaceuticals
CNTA
+$21M

Sector Composition

Rank Sector Weight
1 Healthcare 98.83%
2 Miscellaneous 1.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACHC icon
26
Acadia Healthcare
ACHC
$2.62B
$15.5M 1.33%
524,934
-57,811
-10% -$1.48M
ORKA
27
Oruka Therapeutics
ORKA
$6.13B
$15.1M 1.3%
158,825
-15,227
-9% -$1.01M
OSCR icon
28
Oscar Health
OSCR
$9.95B
$14.8M 1.27%
519,016
+19,179
+4% +$413K
TMO icon
29
Thermo Fisher Scientific
TMO
$227B
$14.3M 1.23%
28,496
+13,664
+92% +$6.56M
CVS icon
30
CVS Health
CVS
$124B
$14.2M 1.22%
+137,457
New +$12.3M
MMSI icon
31
Merit Medical Systems
MMSI
$5.35B
$13.7M 1.17%
197,038
+34,569
+21% +$2.28M
PRAX icon
32
Praxis Precision Medicines
PRAX
$9.82B
$12.9M 1.11%
38,575
+3,137
+9% +$993K
CLDX icon
33
Celldex Therapeutics
CLDX
$3.12B
$12.8M 1.09%
342,751
+17,794
+5% +$575K
NVO
34
Novo Nordisk
NVO
$206B
$12.7M 1.09%
265,016
+67,835
+34% +$2.91M
ITGR icon
35
Integer Holdings
ITGR
$4.3B
$11.8M 1.02%
126,669
-8,412
-6% -$747K
DNTH icon
36
Dianthus Therapeutics
DNTH
$6.05B
$11.8M 1.01%
121,222
-50,915
-30% -$4.45M
DFTX
37
Definium Therapeutics
DFTX
$5.12B
$11.7M 1.01%
249,020
+43,703
+21% +$1.08M
GILD icon
38
Gilead Sciences
GILD
$187B
$11.5M 0.98%
+90,858
New +$12M
RYTM icon
39
Rhythm Pharmaceuticals
RYTM
$7.07B
$11.3M 0.97%
101,550
-35,071
-26% -$3.17M
HSIC icon
40
Henry Schein
HSIC
$10B
$11.2M 0.96%
134,423
-18,691
-12% -$1.43M
ARWR icon
41
Arrowhead Research
ARWR
$12.2B
$10.7M 0.92%
131,667
+67,388
+105% +$4.98M
TNGX icon
42
Tango Therapeutics
TNGX
$3.8B
$10.2M 0.87%
326,047
-80,198
-20% -$1.98M
TFX icon
43
Teleflex
TFX
$5.86B
$10.1M 0.87%
+79,708
New +$10.2M
VKTX icon
44
Viking Therapeutics
VKTX
$4.07B
$9.96M 0.85%
255,330
-7,776
-3% -$251K
BTSG icon
45
BrightSpring Health Services
BTSG
$12B
$9.9M 0.85%
141,914
-45,421
-24% -$2.52M
VERA icon
46
Vera Therapeutics
VERA
$2.59B
$9.62M 0.83%
224,289
+49,422
+28% +$1.84M
ROIV icon
47
Roivant Sciences
ROIV
$25.2B
$9.48M 0.81%
268,008
+60,562
+29% +$1.79M
CGON icon
48
CG Oncology
CGON
$6.62B
$9.11M 0.78%
128,286
-37,639
-23% -$2.46M
AMRX icon
49
Amneal Pharmaceuticals
AMRX
$6.07B
$8.32M 0.71%
480,715
-449,381
-48% -$6.16M
EPRX
50
Eupraxia Pharmaceuticals
EPRX
$555M
$8M 0.69%
1,210,661
+669,790
+124% +$4.62M
1
2
3 4 5

Similar funds

JC
Jacobs & Co San Francisco, California $1.17B AUM 37.3% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
MK
MASTERINVEST Kapitalanlage Vienna $1.16B AUM 40% 1-Year Est. Return
HCP
Hiddenite Capital Partners New York $1.16B AUM 95.58% 1-Year Est. Return
EC
Estate Counselors Thiensville, Wisconsin $1.16B AUM 21.97% 1-Year Est. Return
M
MOTCO San Antonio, Texas $1.17B AUM 23.84% 1-Year Est. Return
CCM
Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return
VFP
Verus Financial Partners Richmond, Virginia $1.17B AUM 15.91% 1-Year Est. Return

PFM Health Sciences's Q2 2026 Portfolio in Review

As of Q2 2026, PFM Health Sciences held 116 positions worth $1.17B, up 6.3% from $1.1B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

PFM Health Sciences's Q2 2026 filing shows 34 new, 23 increased, 41 reduced and 18 closed positions. Its largest new stake was Humana: 94,375 shares worth $37.5M. The largest sale was Tenet Healthcare, an estimated $50M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 85% a quarter earlier, followed by Miscellaneous.

  • PFM Health Sciences's largest Q2 2026 buy was Humana: 94,375 shares worth $37.5M.
  • PFM Health Sciences added most to Ascendis Pharma A/S in Q2 2026, an estimated $19M increase.
  • PFM Health Sciences's biggest Q2 2026 reduction was Tenet Healthcare, cutting an estimated $50M.
  • PFM Health Sciences fully exited Glaukos in Q2 2026, selling an estimated $23.2M.
  • PFM Health Sciences's ten largest holdings make up 34% of its $1.17B portfolio in Q2 2026.
  • PFM Health Sciences opened 34 new positions and closed 18 in Q2 2026.
  • PFM Health Sciences's portfolio value rose 6.3% quarter-over-quarter to $1.17B.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.